文献速递免疫规划

重组百日咳杆菌腺苷酸环化酶(CyaA)携带肺炎链球菌表面蛋白A(PspA)片段诱导的免疫应答及对肺炎链球菌的保护作用

Immune responses and protection against Streptococcus pneumoniae elicited by recombinant Bordetella pertussis adenylate cyclase (CyaA) carrying fragments of pneumococcal surface protein A, PspA.
PubMed 文献 · Vaccine · 2023-05-24

本研究以百日咳杆菌腺苷酸环化酶毒素(CyaA)为载体,在小鼠中测试其递送肺炎链球菌表面蛋白A(PspA)来自分支2和4的N端片段(A2和A4)所诱导的免疫应答。重组CyaA-A2和CyaA-A4蛋白能诱导高水平抗PspA抗体,该抗体与表达PspA2或PspA4的肺炎链球菌菌株反应,也与表达PspA3和PspA5的菌株反应。含CyaA-A2和CyaA-A4的制剂及CyaA-A2-A4融合蛋白均能保护小鼠抵抗表达PspA2、PspA4或PspA5的侵袭性肺炎链球菌攻击。

要点

  • CyaA-A2和CyaA-A4重组蛋白在小鼠中诱导高水平抗PspA抗体。
  • 诱导的抗体与表达PspA2、PspA4、PspA3或PspA5的肺炎链球菌菌株均有反应性。
  • 含CyaA-A2和CyaA-A4的制剂及CyaA-A2-A4融合蛋白均保护小鼠抵抗侵袭性肺炎链球菌攻击。

核心结论

  • CyaA-PspA蛋白是诱导针对肺炎链球菌分离株广谱保护的良好候选疫苗。

研究设计与样本

  • 在小鼠中进行的免疫原性与攻毒保护实验,测试基于百日咳杆菌腺苷酸环化酶毒素(CyaA)递送PspA分支2和4的N端片段(A2和A4)的重组蛋白。

主要发现

  • 重组CyaA-A2和CyaA-A4蛋白能诱导高水平抗PspA抗体,该抗体与表达PspA2或PspA4的肺炎链球菌菌株反应。
  • 抗体的反应性也见于表达PspA3和PspA5的肺炎链球菌菌株。
  • 含CyaA-A2和CyaA-A4的制剂能保护小鼠抵抗表达PspA2、PspA4或PspA5的侵袭性肺炎链球菌攻击。
  • CyaA-A2-A4融合蛋白诱导的抗体水平与反应性与含两种蛋白的制剂相似,并保护小鼠抵抗侵袭性攻击。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Streptococcus pneumoniae is a common agent of important human diseases such as otitis media, pneumonia, meningitis and sepsis. Current available vaccines that target capsular polysaccharides induce protection against invasive disease and nasopharyngeal colonization in children, yet their efficacy is limited to the serotypes included in the formulations. The virulence factor Pneumococcal Surface Protein A (PspA) interacts with host immune system and helps the bacteria to evade phagocytosis. Due to its essential role in virulence, PspA is an important vaccine candidate. Here we have tested a delivery system based on the adenylate cyclase toxin of Bordetella pertussis (CyaA) to induce immune responses against PspA in mice. CyaA was engineered to express fragments of the N-terminal region of PspAs from clades 2 and 4 (A2 and A4) and the resulting proteins were used in immunization experiments in mice. The recombinant CyaA-A2 and CyaA-A4 proteins were able to induce high levels of anti-PspA antibodies that reacted with pneumococcal strains expressing either PspA2 or PspA4. Moreover, reactivity of the antibodies against pneumococcal strains that express PspAs from clades 3 and 5 (PspA3 and PspA5) was also observed. A formulation containing CyaA-A2 and CyaA-A4 was able to protect mice against invasive pneumococcal challenges with isolates that express PspA2, PspA4 or PspA5. Moreover, a CyaA-A2-A4 fusion protein induced antibodies at similar levels and with similar reactivity as the formulation containing both proteins, and protected mice against the invasive challenge. Our results indicate that CyaA-PspA proteins are good candidates to induce broad protection against pneumococcal isolates.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Carneiro GB, Castro JT, Davi M, et al. Immune responses and protection against Streptococcus pneumoniae elicited by recombinant Bordetella pertussis adenylate cyclase (CyaA) carrying fragments of pneumococcal surface protein A, PspA. Vaccine. 2023. PMID: 37236818. doi:10.1016/j.vaccine.2023.05.031

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。